A.R.T. Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-61,177
| Closed | -$230K | – | 1892 |
|
|
2018
Q2 | $230K | Buy |
+61,177
| New | +$230K | 0.01% | 1191 |
|
|
2017
Q2 | – | Sell |
-147,400
| Closed | -$907K | – | 1907 |
|
|
2017
Q1 | $907K | Buy |
+147,400
| New | +$907K | 0.04% | 591 |
|
|
2016
Q4 | – | Sell |
-34,400
| Closed | -$182K | – | 1463 |
|
|
2016
Q3 | $182K | Sell |
34,400
-36,854
| -52% | -$195K | 0.06% | 503 |
|
|
2016
Q2 | $471K | Buy |
+71,254
| New | +$471K | 0.02% | 823 |
|
|
2015
Q3 | – | Sell |
-395,913
| Closed | -$3.95M | – | 1749 |
|
|
2015
Q2 | $3.95M | Buy |
+395,913
| New | +$3.95M | 0.13% | 209 |
|
|
2015
Q1 | – | Sell |
-157,314
| Closed | -$2.23M | – | 1838 |
|
|
2014
Q4 | $2.23M | Buy |
+157,314
| New | +$2.23M | 0.08% | 360 |
|
|
2014
Q2 | – | Sell |
-259,439
| Closed | -$4.42M | – | 1658 |
|
|
2014
Q1 | $4.42M | Buy |
259,439
+171,488
| +195% | +$2.92M | 0.23% | 103 |
|
|
2013
Q4 | $1.14M | Sell |
87,951
-98,398
| -53% | -$1.27M | 0.06% | 430 |
|
|
2013
Q3 | $1.88M | Buy |
186,349
+40,451
| +28% | +$408K | 0.1% | 288 |
|
|
2013
Q2 | $1.09M | Buy |
+145,898
| New | +$1.09M | 0.04% | 601 |
|